Arrow keys move between marks; Enter selects; F opens full screen.

Skip to content
Procura
Get started

Bioradar PBC

Correct this listing

UEIUEI: the 12-character ID the government gives every company registered for federal work. It replaced the DUNS number in April 2022. Glossary NKXFKHMH2WW6· CAGECAGE code: a 5-character code that identifies one company location for federal work. A company with several sites can have several. Glossary 18UE4· WABAN, MA· Active registration until Feb 6, 2027

Overview

Registered industries (NAICS)

Registered in 16 industries; primary 541715

  • 221320 Sewage Treatment Facilities
  • 325414 Biological Product (except Diagnostic) Manufacturing
  • 334516 Analytical Laboratory Instrument Manufacturing
  • 456199 All Other Health and Personal Care Retailers
  • 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
  • 525120 Health and Welfare Funds
  • 541380 Testing Laboratories and Services
  • 541511 Custom Computer Programming Services
  • 541512 Computer Systems Design Services
  • 541611 Administrative Management and General Management Consulting Services
  • 541690 Other Scientific and Technical Consulting Services
  • 541713 Research and Development in Nanotechnology
  • 541714 Research and Development in Biotechnology (except Nanobiotechnology)
  • 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  • 541990 All Other Professional, Scientific, and Technical Services
  • 624230 Emergency and Other Relief Services

No prime contract or subcontract to this company appears in the federal contract records from FY2001 on.

About

From the company's SBA profile, updated Feb 2026

BioRadar PBC is an AI-powered biosurveillance company that detects unknown and anomalous biological threats before they become outbreaks. Our platform fuses wastewater metagenomic sequencing with syndromic surveillance and multi-source environmental and behavioral data into a single situational awareness layer, using machine learning to flag anomalies that traditional targeted testing would miss. The technology is inherently dual-use: the same detection architecture that identifies naturally emerging infectious disease also surfaces signatures consistent with deliberately released pathogens, making it equally relevant to public health surveillance and biodefense missions.